Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial
Authors:
Open Access
- 9 January 2025
- journal article
- research article
- Published by Elsevier in The Lancet Child & Adolescent Health
- Vol. 9 (2) , 121-130
Abstract
No abstract availableKeywords
Funding Information
- University Hospital Southampton NHS Foundation Trust
- Oxford University Hospitals NHS Foundation Trust
- Health Technology Assessment Programme (15/188/42)
- Cancer Research UK
- Public Health Wales
- Alder Hey Children's NHS Foundation Trust
- Health and Care Research Wales
- University Hospitals Plymouth NHS Trust
- National Institute for Health and Care Research
- University Hospitals Bristol NHS Foundation Trust
This publication has 36 references indexed in Scilit:
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Paediatric antimicrobial stewardship programmes in the UK's regional children's hospitalsJournal of Hospital Infection, 2020
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisThe Lancet Infectious Diseases, 2019
- Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)The Lancet, 2017
- Early procalcitonin kinetics and appropriateness of empirical antimicrobial therapy in critically ill patientsJournal of Critical Care, 2016
- Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trialThe Lancet Infectious Diseases, 2016
- A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled TrialsPharmacoEconomics, 2014
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Challenge of multiple co‐primary endpoints: a new approachStatistics in Medicine, 2006
- Procalcitonin as a marker of sepsisInternational Journal of Antimicrobial Agents, 2002